403 completed, 90 recruiting, 84 unknown, 59 terminated. 132 Phase 3, 109 Not applicable, 83 Phase 2, 68 Phase 4, 22 Phase 1.
Follow Venous Thromboembolism: new trials by email Literature Review of Venous Thromboembolism trials Research Report on Venous Thromboembolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE) Rivaroxaban (Xarelto, BAY59-7939), Standard of care (SOC) - Venous Thromboembolism, Children Under 2 Years | Not yet recruiting | Bayer | 850 | 2027-09-01 | 2026-10-02 | |
| Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP). Enoxaparin - Venous Thromboembolism (VTE) | Phase 3 | Not yet recruiting | Johns Hopkins All Children's Hospital | 802 | 2027-04-15 | 2026-05-26 |
| Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism edoxaban, Apixaban - Venous Thromboembolism, Active Cancer | Phase 4 | Not yet recruiting | Samsung Medical Center | 2300 | 2026-11-01 | 2026-10-01 |
| Comparison of Thrombin Generation, Platelet Activation and Aggregation Profiles in Patients With Sickle Cell Disease Depending on Their SS or SC Genotype (DrepAgreg) Sickle Cell Disease, Venous Thromboembolism | Not yet recruiting | Centre Hospitalier Universitaire de la Guadeloupe | 60 | 2026-10-15 | 2026-10-01 | |
| Vortosiran for VTE Prevention Vortosiran, Placebo - Venous Thromboembolism (VTE), Cancer | Phase 2 | Not yet recruiting | Ribocure Pharmaceuticals AB | 150 | 2026-10-01 | 2026-09-30 |
| Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee Arthroplasty Apixaban, Rivaroxaban, Enoxaparin (LMWH) - Total Knee Arthroplasty, Venous Thromboembolism | Not applicable | Recruiting | Military Hospital of Tunis | 138 | 2026-09-15 | 2026-10-16 |
| Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC) REGN7508, REGN9933, Placebo - Venous Thromboembolism (VTE) | Phase 3 | Recruiting | Regeneron Pharmaceuticals | 1908 | 2026-09-07 | 2026-09-29 |
| Risk Factors of Venous Thrombotic Event in Interstitial Lung Disease Interstitial Lung Disease, Venous Thromboembolism | Not yet recruiting | Sohag University | 100 | 2026-09-01 | 2026-09-22 | |
| Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism DECIDE-VTE Patient Decision Aid - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT) | Not applicable | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 850 | 2026-09-01 | 2026-06-24 |
| Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity | Recruiting | The University of Texas Health Science Center, Houston | 40 | 2026-08-26 | 2026-10-02 | |
| Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers REGN7508, Apixaban - Venous Thromboembolism (VTE) | Phase 3 | Recruiting | Regeneron Pharmaceuticals | 1600 | 2026-08-26 | 2026-10-21 |
| Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism mobile venous thromboembolism application (mVTEA) - Venous Thromboembolism, Pulmonary Thromboembolisms | Not applicable | Recruiting | Navy General Hospital, Beijing | 2972 | 2026-08-20 | 2026-09-09 |
| Focused Ultrasound of the Popliteal Fossa for Detection of Symptomatic Baker's Cysts in Patients With Suspected Deep Vein Thrombosis: A Pilot Diagnostic Accuracy Study Index Test (Focused Ultrasound of the Popliteal Fossa), Reference test (Routine DVT Diagnostic Pathway) - Baker's Cyst | Recruiting | Aarhus University Hospital | 150 | 2026-08-03 | 2026-08-27 | |
| Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease Apixaban - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT) | Phase 4 | Not yet recruiting | James Bayley | 50 | 2026-08-01 | 2026-07-20 |
| The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial. Anti-Xa Activity Monitoring, Tinzaparin (Leo), enoxaparin - Bariatric Surgery, Anti-Xa Activity | Not applicable | Not yet recruiting | University College Dublin | 180 | 2026-08-01 | 2026-05-18 |
| Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study) Systematic screening for pulmonary embolism in all patients using a guideline-recommended diagnostic algorithm - Acute Heart Failure (AHF), Pulmonary Embolism (Diagnosis) | Not applicable | Recruiting | University Hospital, Angers | 740 | 2026-07-15 | 2026-07-17 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection YKYY033 Injection, YKYY033 Placebo - Venous Thromboembolism (VTE) | Phase 1 | Recruiting | Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. | 40 | 2026-07-10 | 2026-08-26 |
| Delivery and Implementation of a Randomised Crossover Trial on Thrombosis Patients in hospitals allocated to this arm will receive aspirin as their routine thromboprophylaxis after surgery., Low molecular weight heparin (LMWH) - Hip Fractures, Venous Thromboembolism (VTE) | Not applicable | Recruiting | Queen Mary University of London | 21194 | 2026-07-01 | 2026-09-23 |
| Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance Routine clinical care (no study intervention) - Venous Thromboembolism (VTE), Chronic Thromboembolic Pulmonary Hypertension | Recruiting | Azienda Ospedaliero-Universitaria Careggi | 5000 | 2026-06-19 | 2026-10-15 | |
| Statins to Prevent Cancer Associated Blood Clots Rosuvastatin, Placebo Drug - Venous Thromboembolism, Cancer | Phase 4 | Recruiting | Brigham and Women's Hospital | 4000 | 2026-06-11 | 2026-09-16 |
Showing 20 of 696. Sign in to see all of them.
Venous Thrombosis (196) · Pulmonary Embolism (184) · Thrombosis (57) · Neoplasms (56) · Thromboembolism (43) · Atrial Fibrillation (35) · Hemorrhage (29) · Cardiovascular Diseases (21) · Embolism and Thrombosis (13) · Wounds and Injuries (13) · COVID-19 (12) · Critical Illness (12) · Multiple Myeloma (10) · Thrombophilia (10)
Vascular Diseases (689) · Embolism and Thrombosis (683) · Cardiovascular Diseases (675) · Thromboembolism (653) · Respiratory Tract Diseases (206) · Lung Diseases (202) · Embolism (182) · Thrombosis (176) · Pathological Conditions, Signs and Symptoms (141) · Pathologic Processes (127) · Neoplasms (61) · Neoplasms by Site (51) · Heart Diseases (46) · Nervous System Diseases (44) · Hemic and Lymphatic Diseases (40)
Enoxaparin (88) · Rivaroxaban (88) · apixaban (60) · Heparin, Low-Molecular-Weight (31) · Warfarin (30) · Dalteparin (29) · Aspirin (28) · Dabigatran (25) · edoxaban (21) · Fondaparinux (18) · Tinzaparin (18) · enoxaparin sodium (17) · Heparin (15) · Standard of Care (11) · AVE 5026 (8)
Bayer (35) · Ottawa Hospital Research Institute (21) · University Hospital, Brest (19) · Boehringer Ingelheim (16) · McMaster University (14) · Brigham and Women's Hospital (13) · Sanofi (13) · University of Utah (11) · Bristol-Myers Squibb (10) · Daiichi Sankyo (9) · GlaxoSmithKline (8) · Regeneron Pharmaceuticals (8) · Astellas Pharma Inc (6) · Daiichi Sankyo Co., Ltd. (6) · Hamilton Health Sciences Corporation (6)
United States (216) · Canada (117) · France (106) · Italy (72) · Germany (61) · China (59) · United Kingdom (54) · Spain (51) · Netherlands (49) · Russia (46) · Denmark (42) · Sweden (41) · Switzerland (39) · Austria (38) · Poland (37)
Christopher Puccini, MD (4) · Sam Schulman, MD, PhD (4) · Shirley Wang, PhD, ScM (4) · Takeshi Fuji (4) · Alexander Turpie, MD (3) · Guy Meyer, MD (3) · Kirill Lobastov, PhD (3)
PMID 33337539, PMID 33779986, PMID 33086312, PMID 35244208, PMID 22429800, PMID 28762617, PMID 33502773, PMID 34172290, PMID 34622445, PMID 34878173, PMID 15319720, PMID 22863355, PMID 24251360, PMID 27980462, PMID 28063245, PMID 28617144, PMID 29452956, PMID 29649055, PMID 31420317, PMID 32657973, PMID 34597414, PMID 35876829, PMID 36150047, PMID 38348778, PMID 38844941, PMID 39238110, PMID 39968829, PMID 40163217, PMID 41218619, PMID 10453824, PMID 10499070, PMID 10546719, PMID 11867132, PMID 11982463, PMID 12083490, PMID 12131409, PMID 12387283, PMID 12709915, PMID 12763484, PMID 12825542, PMID 14715365, PMID 14987333, PMID 15132746, PMID 15234649, PMID 15383488, PMID 15471507, PMID 15701913, PMID 15811953, PMID 15842354, PMID 16009794
2014 (7), 2023 (6), 2016 (5), 2025 (5), 2009 (4), 2008 (3), 2015 (3), 2017 (3), 2019 (3), 2005 (2), 2018 (2), K23HL132054 (2), P30CA015704 (1), P30CA138313 (1), P50HL054502 (1)